October 27, 2019
Treventis attends the 2nd Neuromuscular Drug Development Summit (NMD)
CEO Christopher Barden attended the NMD Summit in Boston, Massachusetts, where he spoke with therapeutic and diagnostic companies that are...
Read More
October 24, 2019
Treventis scientists visit Society for Neuroscience conference
Treventis was represented at the 50th Society for Neuroscience Conference in Chicago, Illinois, one of the world’s largest conferences dedicated...
Read More
September 18, 2019
Treventis CEO invited speaker, panelist at XV International Pharma Licensing Symposium
Treventis CEO Christopher Barden was honored to be an invited speaker at the XV International Pharma Licensing Symposium, running from...
Read More
September 18, 2019
Treventis attends 4th Zebrafish for Personalized & Precision Medicine Conference
Treventis was represented at the 4th Zebrafish for Personalized & Precision Medicine Conference, running from Sep 18-20, 2019, in Toronto,...
Read More
July 14, 2019
Treventis founders present research at AAIC 2019
Treventis was well represented at the Alzheimer Association International Conference, running from Jul 14-18, 2019, in Los Angeles, California. In...
Read More
June 3, 2019
Treventis attends the BIO International Convention, gives ‘Buzz of BIO’ presentation
Treventis attended the BIO International Convention that took place on June 3-6 in Philadelphia, Pennsylvania, with more than 16,000 attendees...
Read More
April 1, 2019
Treventis attends AD/PD 2019
Treventis scientists attended the 14th International Conference on Alzheimer's & Parkinson's Diseases and Related Neurological Disorders held on March 26-31...
Read More
March 21, 2019
Treventis adds to Scientific Advisory Board
FEB 22, 2019 - Treventis is pleased to announce that internationally recognized ALS researcher Dr. Janice Robertson has joined its...
Read More
February 22, 2019
Treventis attends the 7th World CNS Summit
CSO Mark Reed attended the 7th World CNS Summit in Boston, Massachusetts. This industry-focused event is aimed at fostering translational...
Read More
October 4, 2018
Treventis founder Sultan Darvesh presents invited CANP lecture
Dr. Sultan Darvesh, neurologist, medicinal chemist, and Treventis founder was as an invited lecturer to the 58th annual Canadian Association...
Read More